|
🐜
|
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
9 auth.
J. Krystal,
L. Karper,
J. Seibyl,
G. K. Freeman,
R. Delaney,
J. Bremner,
...
G. Heninger,
M. Bowers,
D. Charney
|
11 |
1994 |
11
🐜
|
|
🐜
|
Interactive effects of subanesthetic ketamine and haloperidol in healthy humans
12 auth.
John H. Krystal,
D. D’Souza,
L. Karper,
A. Bennett,
A. Abi-Dargham,
D. Abi‐Saab,
...
K. Cassello,
M. B. Bowers Jr.,
S. Vegso,
G. Heninger,
D. S. Charney,
M. B. Bowers
|
7 |
1999 |
7
🐜
|
|
🐜
|
Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions
9 auth.
J. Krystal,
A. Bennett,
D. Abi‐Saab,
A. Belger,
L. Karper,
D. D’Souza,
...
D. Lipschitz,
A. Abi-Dargham,
D. Charney
|
7 |
2000 |
7
🐜
|
|
🐜
|
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans
13 auth.
John H. Krystal,
L. Karper,
A. Bennett,
D. D’Souza,
A. Abi-Dargham,
K. Morrissey,
D. Abi‐Saab,
J. Bremner,
M. B. Bowers Jr.,
Raymond F. Suckow,
...
P. Stetson,
G. Heninger,
D. S. Charney
|
7 |
1998 |
7
🐜
|
|
🐜
|
Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics.
9 auth.
John H. Krystal,
I. Petrakis,
E. Webb,
Ned L. Cooney,
L. Karper,
Sheila N. Namanworth,
...
Philip Stetson,
Louis Trevisan,
D. S. Charney
|
7 |
1998 |
7
🐜
|
|
🦁
|
Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis.
L. Karper,
G. K. Freeman,
Christian Grillon,
C. A. M. rd,
D. S. Charney,
J. Krystal
|
7 |
1996 |
7
🦁
|
|
🐜
|
Psychiatric safety of ketamine in psychopharmacology research
12 auth.
E. Perry,
J. Cramer,
H. Cho,
I. Petrakis,
L. Karper,
A. Genovese,
...
O. Elizabeth,
Donnell,
J. Krystal,
D. D.Cyril,
Souza,
Yale Ketamine
|
6 |
2007 |
6
🐜
|
|
🐜
|
IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans
12 auth.
D. D’Souza,
R. Gil,
K. Cassello,
K. Morrissey,
D. Abi‐Saab,
Jonathan White,
...
R. Sturwold,
A. Bennett,
L. Karper,
E. Zuzarte,
D. Charney,
J. Krystal
|
6 |
2000 |
6
🐜
|
|
🐜
|
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine
13 auth.
H. Cho,
D. D’Souza,
R. Gueorguieva,
E. Perry,
S. Madonick,
L. Karper,
A. Abi-Dargham,
A. Belger,
W. Abi-Saab,
D. Lipschitz,
...
A. Bennet,
J. Seibyl,
J. Krystal
|
5 |
2005 |
5
🐜
|
|
🐜
|
Clinical significance of neurological soft signs in schizophrenia: Factor analysis of the Neurological Evaluation Scale
11 auth.
R. A. Sewell,
E. Perry,
L. Karper,
M. Bell,
Paul H. Lysaker,
J. Goulet,
...
L. Brenner,
J. Erdos,
D. D’Souza,
J. Seibyl,
J. Krystal
|
5 |
2010 |
5
🐜
|
|
🦁
|
The effect of ketamine on pre-pulse inhibition and attention
L. Karper,
C. Grillon,
D. Abi‐Saab,
C. A. Morgan,
D. Charney,
J. Krystal
|
4 |
1995 |
4
🦁
|
|
🐜
|
Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms
12 auth.
W. Abi-Saab,
J. Seibyl,
C. D’Souza,
L. Karper,
Ralitza Gueorgueva,
A. Abi-Dargham,
...
M. Wong,
Sachin Rajhans,
J. Erdos,
G. Heninger,
D. Charney,
J. Krystal
|
4 |
2002 |
4
🐜
|
